Hercules Capital, Inc. Stock: price and management transactions · United States · SEC (Form 4)

About Hercules Capital, Inc.

Hercules Capital, Inc. (NYSE: HTGC) is a U.S.-based specialty finance company headquartered in San Mateo, California, United States. For French-speaking investors, it is best understood as a leading business development company (BDC) focused on venture lending: providing debt capital to innovative, venture capital-backed companies. Hercules describes itself as the largest and leading specialty finance company concentrated on this niche, and as a lender of choice for innovative entrepreneurs and their venture capital sponsors. ([htgc.com](https://www.htgc.com/about/?utm_source=openai)) The company’s core activity is senior secured lending and growth financing for companies in high-innovation sectors, especially technology and life sciences. Its financing solutions typically support growth capital needs, expansion, product development, working capital, and other strategic corporate initiatives. In practice, Hercules offers an alternative to conventional commercial bank lending, with a more tailored and flexible structure designed for companies that may be too early, too specialized, or too growth-oriented for traditional lenders. ([htgc.com](https://www.htgc.com/about/?utm_source=openai)) Hercules Capital’s business model is closely tied to the venture ecosystem. It has built its franchise by serving venture-backed businesses at different stages, from earlier growth companies to more established issuers that still need non-dilutive capital. The firm’s headquarters are in San Mateo, California, and its operating footprint is primarily U.S.-centric, although its client base can include companies with broader domestic or international ambitions depending on their financing needs. ([htgc.com](https://www.htgc.com/contact-us/?utm_source=openai)) From a competitive standpoint, Hercules benefits from deep sector specialization, strong relationships with venture capital firms, and a long-standing reputation in a relatively niche corner of the credit market. That specialization matters: technology and life sciences borrowers often require financing that is more flexible than bank debt but less dilutive than equity. Hercules is positioned to fill that gap, which supports its market relevance and gives it access to a differentiated deal flow versus more generalist lenders. ([htgc.com](https://www.htgc.com/about/?utm_source=openai)) Recent developments have remained supportive of the investment case. In May 2025 and again in May 2026, Hercules reported quarterly results highlighting strong originations and liquidity levels above $1.0 billion at quarter-end. The company also disclosed record new debt and equity commitments in Q1 2026, indicating that demand for its capital remains robust. For investors following SEC Form 4 insider transactions, HTGC is therefore a name to watch both for credit performance and for management confidence signals through insider activity. ([businesswire.com](https://www.businesswire.com/news/home/20250501258025/en/Hercules-Capital-Reports-First-Quarter-2025-Financial-Results?utm_source=openai))